2seventy bio vs Merus N.V.
2seventy bio
It’s about time we think smarter and faster than cancer
122 employees · est. 2021 · Cambridge, United States
Merus N.V.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c
185 employees · est. 2003 · Utrecht, The Netherlands
Merus N.V. is the older company (2021 vs 2003).
Side-by-Side Comparison
| Metric | 2seventy bio | Merus N.V. |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2003 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Utrecht, The Netherlands |
| Employees | ||
| Employees | 122 | 185 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $614.62M | $1.04B |
| Funding Rounds | ||
| Funding Rounds | 4 | 11 |
| Services | ||
| Services | Research & Development, Clinical Trials, Product Development, Scientific Resources Provision, Medicines Access and Support | Development of Cancer Treatments, Clinical Trials Management, Research and Development in Biotechnology, Multiclonics Therapeutics |
| Target Customers | ||
| Target Customers | Patients with Cancer, Patients with Hematological Diseases, Neurological and Psychiatric Patients, Healthcare Providers, Patient Advocacy Groups, Medical Researchers | Cancer Patients, Healthcare Providers, Medical Researchers, Pharmaceutical Industry |
| Taxonomy | ||
| Taxonomy | Immuno-oncologyCell TherapyCancer TreatmentCancer Cell MetabolismGenomicsImmune Response +8 | Biclonics®Bispecific Antibody TherapeuticsAntibody-based BiopharmaceuticalsOligoclonics TechnologyImmuno-oncologyCancer Treatment +9 |
| Website | ||
| Website | 2seventybio.com | merus.nl |
About 2seventy bio
2seventy bio is a progressive player in the field of immuno-oncology cell therapy, founded in 2021. With its headquarters in the United States, the company is dedicated to altering the future of cancer treatment. Their innovative approach is encapsulated in the slogan, "It’s about time we think smar...
About Merus N.V.
Merus N.V., a biotechnology firm founded in 2003, is headquartered in The Netherlands. The company is at the forefront of developing innovative oncology solutions using its proprietary Biclonics® bispecific antibody therapeutics. This pioneering approach enables simultaneous multi-targeted tumor att...
Also comparing in this category
Comparing more than these two?
Get 2seventy bio, Merus N.V. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does 2seventy bio compare?
A PDF of 2seventy bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare 2seventy bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at 2seventy bio on 3 Jul 2026, and Merus N.V. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
